Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Artivion, Inc. stock logo
AORT
Artivion
$43.87
+0.1%
$34.80
$21.97
$45.07
$2.07B1.64445,433 shs342,981 shs
Enovis Corporation stock logo
ENOV
Enovis
$30.88
+1.0%
$30.05
$25.47
$49.83
$1.77B1.71.19 million shs846,163 shs
National Vision Holdings, Inc. stock logo
EYE
National Vision
$22.94
-2.0%
$24.11
$9.56
$25.67
$1.82B1.272.11 million shs2.35 million shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$18.88
-0.1%
$14.81
$8.15
$19.00
$532.42M2.2288,828 shs300,975 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Artivion, Inc. stock logo
AORT
Artivion
+0.11%+1.59%+38.96%+48.07%+65.44%
Enovis Corporation stock logo
ENOV
Enovis
-1.54%+3.95%+11.87%-2.31%-32.49%
National Vision Holdings, Inc. stock logo
EYE
National Vision
-4.06%-2.66%-4.68%+18.12%+122.43%
ZimVie Inc. stock logo
ZIMV
ZimVie
-0.37%-0.16%+0.48%+106.33%+10.59%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Artivion, Inc. stock logo
AORT
Artivion
3.2455 of 5 stars
2.55.00.00.02.22.51.9
Enovis Corporation stock logo
ENOV
Enovis
4.5382 of 5 stars
4.53.00.00.04.13.31.9
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.7506 of 5 stars
2.32.00.03.33.70.00.0
ZimVie Inc. stock logo
ZIMV
ZimVie
0.6658 of 5 stars
1.03.00.00.02.91.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Artivion, Inc. stock logo
AORT
Artivion
3.00
Buy$40.63-7.01% Downside
Enovis Corporation stock logo
ENOV
Enovis
3.00
Buy$51.0066.73% Upside
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.60
Moderate Buy$24.737.42% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.00
Hold$17.75-6.11% Downside

Current Analyst Ratings Breakdown

Latest ZIMV, AORT, EYE, and ENOV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/22/2025
Artivion, Inc. stock logo
AORT
Artivion
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$45.00 ➝ $50.00
8/13/2025
Artivion, Inc. stock logo
AORT
Artivion
LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$32.00 ➝ $38.80
8/8/2025
Artivion, Inc. stock logo
AORT
Artivion
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
8/8/2025
Artivion, Inc. stock logo
AORT
Artivion
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$35.00 ➝ $41.00
8/8/2025
Artivion, Inc. stock logo
AORT
Artivion
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Outperform ➝ Market Outperform$33.00 ➝ $42.00
8/8/2025
Artivion, Inc. stock logo
AORT
Artivion
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$36.00 ➝ $40.00
8/8/2025
Artivion, Inc. stock logo
AORT
Artivion
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$32.00 ➝ $45.00
8/8/2025
Enovis Corporation stock logo
ENOV
Enovis
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$70.00 ➝ $58.00
8/8/2025
Enovis Corporation stock logo
ENOV
Enovis
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$65.00 ➝ $57.00
8/8/2025
Enovis Corporation stock logo
ENOV
Enovis
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$48.00 ➝ $41.00
8/7/2025
Enovis Corporation stock logo
ENOV
Enovis
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$57.00 ➝ $49.00
(Data available from 8/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Artivion, Inc. stock logo
AORT
Artivion
$388.54M5.31$0.83 per share52.43$8.90 per share4.91
Enovis Corporation stock logo
ENOV
Enovis
$2.11B0.83$19.00 per share1.61$45.15 per share0.68
National Vision Holdings, Inc. stock logo
EYE
National Vision
$1.82B1.00$1.54 per share14.91$10.74 per share2.14
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M1.19$1.85 per share10.21$14.64 per share1.29
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Artivion, Inc. stock logo
AORT
Artivion
-$13.36M-$0.42N/A87.39N/A-4.43%5.70%2.29%11/6/2025 (Estimated)
Enovis Corporation stock logo
ENOV
Enovis
-$825.49M-$14.25N/A9.59N/A-37.80%6.78%3.73%11/5/2025 (Estimated)
National Vision Holdings, Inc. stock logo
EYE
National Vision
-$28.50M-$0.18N/A85.262.88-0.75%3.56%1.49%11/5/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.70N/AN/A-4.39%6.37%3.34%10/29/2025 (Estimated)

Latest ZIMV, AORT, EYE, and ENOV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Artivion, Inc. stock logo
AORT
Artivion
$0.11$0.24+$0.13$0.03$107.96 million$112.97 million
8/7/2025Q2 2025
Enovis Corporation stock logo
ENOV
Enovis
$0.74$0.79+$0.05-$0.64$555.80 million$564.50 million
8/6/2025Q2 2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
$0.12$0.18+$0.06$0.11$469.21 million$486.42 million
7/30/2025Q2 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.2080$0.26+$0.0520-$0.14$112.60 million$116.66 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Artivion, Inc. stock logo
AORT
Artivion
N/AN/AN/AN/AN/A
Enovis Corporation stock logo
ENOV
Enovis
N/AN/AN/AN/AN/A
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Artivion, Inc. stock logo
AORT
Artivion
0.52
4.78
3.48
Enovis Corporation stock logo
ENOV
Enovis
0.53
2.25
1.15
National Vision Holdings, Inc. stock logo
EYE
National Vision
0.30
0.52
0.31
ZimVie Inc. stock logo
ZIMV
ZimVie
0.56
2.37
1.60

Institutional Ownership

CompanyInstitutional Ownership
Artivion, Inc. stock logo
AORT
Artivion
86.37%
Enovis Corporation stock logo
ENOV
Enovis
98.45%
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/A
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
Artivion, Inc. stock logo
AORT
Artivion
7.60%
Enovis Corporation stock logo
ENOV
Enovis
2.70%
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.70%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
Artivion, Inc. stock logo
AORT
Artivion
1,60047.18 million43.60 millionOptionable
Enovis Corporation stock logo
ENOV
Enovis
7,36757.16 million55.62 millionOptionable
National Vision Holdings, Inc. stock logo
EYE
National Vision
13,41179.20 million77.06 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77028.20 million27.35 millionOptionable

Recent News About These Companies

ZimVie Reports Second Quarter 2025 Financial Results
Insights into ZimVie's Upcoming Earnings
ZimVie to sell to investment firm for about $730M

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Artivion stock logo

Artivion NYSE:AORT

$43.87 +0.06 (+0.13%)
Closing price 03:59 PM Eastern
Extended Trading
$43.94 +0.08 (+0.18%)
As of 05:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

Enovis stock logo

Enovis NYSE:ENOV

$30.88 +0.29 (+0.96%)
Closing price 03:59 PM Eastern
Extended Trading
$31.53 +0.65 (+2.09%)
As of 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

National Vision stock logo

National Vision NASDAQ:EYE

$22.94 -0.46 (-1.97%)
Closing price 04:00 PM Eastern
Extended Trading
$22.94 -0.01 (-0.02%)
As of 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$18.88 -0.02 (-0.11%)
Closing price 04:00 PM Eastern
Extended Trading
$18.82 -0.06 (-0.30%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.